Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
The Chairman will vote for 10.606.127 shares (or 9,14%) and the Interim CEO & CFO will vote for 20.696.277 shares (or 17,84%)
PRESS RELEASE
Oslo, 27 June 2023
Nordic Nanovector ASA: Disclosure of proxies for the annual general meeting
The chairman of the board of directors of Nordic Nanovector ASA (the "Company" or "NANOV"), Jon Magne Asmyr, has received proxies without voting instructions for a total of 6456 127 shares, corresponding to approx. 5,56 % of the outstanding shares and votes, in connection with the Company's annual general meeting to be held on 28 June 2023 ("AGM"). Jon Magne Asmyr also controls 4150 000 privately owned shares in the Company, corresponding to approx. 3,58% of the outstanding shares and votes. Consequently, Jon Magne Asmyr will vote for a total of 10606 127 shares at the AGM, corresponding to an aggregate of 9,14% of the outstanding shares and votes in the Company, and will exceed the 5% threshold pursuant to section 4-2 of the Norwegian Securities Trading Act, cf. section 4-4.
The interim CEO and CFO of the Company, Ludvik Sandnes, has received proxies without voting instructions for a total of 20596 277 shares, corresponding to approx. 17,75% of the outstanding shares and votes, in connection with the AGM. Ludvik Sandnes also controls 100% of the shares in Ekornhuset AS, a company holding 100 000 shares in the Company, corresponding to approx. 0,09% of the outstanding shares and votes. Consequently, Ludvik Sandnes will vote for a total of 20696 277 shares at the AGM, corresponding to an aggregate of 17,84% of the outstanding shares and votes in the Company, and will exceed the 15% threshold pursuant to section 4-2 of the Norwegian Securities Trading Act, cf. section 4-4.
This information is subject to the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act.